journal article·2025-08-21Open access

Hydrothermal Magnesium Alloy Extracts Modulate MicroRNA Expression in RAW264.7 Cells: Implications for Bone Remodeling

Viviana Costa, Lavinia Raimondi, Daniele Bellavia, Angela De Luca, Pasquale Guglielmi, Angela Cusanno, Luca Cattini, Lia Pulsatelli, Matteo Pavarini, Roberto Chiesa, Gianluca Giavaresi

Abstract

Magnesium (Mg) alloys, particularly Mg AZ31, have emerged as promising biomaterials for orthopedic applications due to their biodegradability and favorable mechanical characteristics. Among these, the Mg AZ31+SPF alloy, subjected to hydrothermal (HT) treatment, has demonstrated enhanced bioactivity. Our previous research established that this surface modification supports the osteogenic differentiation of human mesenchymal stem cells (hMSCs) by modulating both canonical and non-canonical signaling pathways, including those implicated in osteogenesis, hypoxic response, exosome biogenesis, and lipid metabolism. In the present study, we extended our investigation to assess the effects of Mg AZ31+SPF+HT and Mg AZ31+SPF extracts on murine pre-osteoclasts (RAW 264.7 cells) over 3- and 6-day treatment periods. The primary objectives were to evaluate biocompatibility and to investigate potential impacts on osteoclastogenesis induction and miRNA expression profiles. Methods: To assess cytocompatibility, metabolic activity, DNA integrity, and morphological alterations in RAW 264.7 cells were evaluated. Osteoclast differentiation was quantified using TRAP staining, alongside the assessment of osteoclastogenic marker expression by qRT-PCR and ELISA. The immunomodulatory properties of the extracts were examined using multiplex BioPlex assays to quantify soluble factors involved in bone healing. Additionally, global miRNA expression profiling was performed using a specialized panel targeting 82 microRNAs implicated in bone remodeling and inflammatory signaling. Results: Mg AZ31+SPF+HT extract exhibited high biocompatibility, with no observable adverse effects on cell viability. Notably, a significant reduction in the number of TRAP-positive and multinucleated cells was observed relative to the Mg AZ31+SPF group. This effect was corroborated by the downregulation of osteoclast-specific gene expression and decreased MMP9 protein levels. Cytokine profiling indicated that Mg AZ31+SPF+HT extract promoted an earlier release of key cytokines involved in maintaining the balance between bone formation and resorption, suggesting a beneficial role in bone healing. Furthermore, miRNA profiling revealed a distinct regulatory signature in Mg AZ31+SPF+HT-treated cells, with differentially expressed miRNAs associated with inflammation, osteoclast differentiation, apoptosis, bone resorption, hypoxic response, and metabolic processes compared to Mg AZ31+SPF-treated cells. Conclusions: Collectively, these findings indicate that hydrothermal treatment of Mg AZ31+SPF (resulting in Mg AZ31+SPF+HT) attenuates pre-osteoclast activation by influencing cellular morphology, gene and protein expression, as well as post-transcriptional regulation via modulation of miRNAs. The preliminary identification of miRNAs and the activation of their regulatory networks in pre-osteoclasts exposed to hydrothermally treated Mg alloy are described herein. In the context of orthopedic surgery—where balanced bone remodeling is imperative—our results emphasize the dual significance of promoting bone formation while modulating bone resorption to achieve optimal implant integration and ensure long-term bone health.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Magnesium Alloys: Properties and Applications · Bone Tissue Engineering Materials · Magnesium in Health and Disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Surgical Sciences and Technologies-SS Omics Science Platform for Personalized Orthopedics, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy

Department of Mechanics, Mathematics and Management, Politecnico University of Bari, 70125 Bari, Italy

Laboratory of Immunorheumatology and Tissue Regeneration, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, 40136 Bologna, Italy

Department of Chemistry, Materials and Chemical Engineering ‘G. Natta’, Politecnico di Milano, 20135 Milan, Italy

Funding

CONTACT project “CustOm-made aNTibacteri-al/bioActive/bioCoated prosTheses” · PON R&I Funds 2014-2020 and FSC · Ministry of University and Research

References (43)

Show source-provided references
1. Magnesium Alloys for Orthopedic Applications:A Review on the Mechanisms Driving Bone Healing10.1016/j.jma.2022.11.014 ↗
2. Functionalized Magnesium Alloys Obtained by Superplastic Forming Process Retain Osteoinductive and Antibacterial Properties: An in-Vitro Study10.1016/j.dental.2024.01.005 ↗
3. De Luca, A., Ruggiero, R., Cordaro, A., Marrelli, B., Raimondi, L., Costa, V., Bellavia, D., Aiello, E., Pavarini, M., and Piccininni, A. (2024). Towards Accurate Biocompatibility: Rethinking Cytotoxicity Evaluation for Biodegradable Magnesium Alloys in Biomedical Applications. J. Funct. Biomater., 15.10.3390/jfb15120382 ↗
4. Bordukalo-Nikšić, T., Kufner, V., and Vukičević, S. (2022). The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications. Front. Immunol., 13.10.3389/fimmu.2022.869422 ↗
5. Sun, Y., Li, J., Xie, X., Gu, F., Sui, Z., Zhang, K., and Yu, T. (2021). Macrophage-Osteoclast Associations: Origin, Polarization, and Subgroups. Front. Immunol., 12.10.3389/fimmu.2021.778078 ↗
6. Osteoblasts/Stromal Cells Stimulate Osteoclast Activation through Expression of Osteoclast Differentiation Factor/RANKL but Not Macrophage Colony-Stimulating Factor10.1016/S8756-3282(99)00210-0 ↗
7. Tong, X., Yu, G., Fu, X., Song, R., Gu, J., and Liu, Z. (2022). A Review of Signaling Transduction Mechanisms in Osteoclastogenesis Regulation by Autophagy, Inflammation, and Immunity. Int. J. Mol. Sci., 23.10.3390/ijms23179846 ↗
8. Müller, E., Schoberwalter, T., Mader, K., Seitz, J.-M., Kopp, A., Baranowsky, A., and Keller, J. (2024). The Biological Effects of Magnesium-Based Implants on the Skeleton and Their Clinical Implications in Orthopedic Trauma Surgery. Biomater. Res., 28.10.34133/bmr.0122 ↗
9. Biodegradable Mg-Based Alloys: Biological Implications and Restorative Opportunities10.1080/09506608.2022.2079367 ↗
10. Effects of Extracellular Magnesium on the Differentiation and Function of Human Osteoclasts10.1016/j.actbio.2014.02.010 ↗
11. A View of Magnesium Alloy Modification and Its Application in Orthopedic Implants10.1016/j.jmrt.2025.03.188 ↗
12. miR-31 Controls Osteoclast Formation and Bone Resorption by Targeting RhoA10.1186/ar4282 ↗
13. Inoue, K., Ng, C., Xia, Y., and Zhao, B. (2021). Regulation of Osteoclastogenesis and Bone Resorption by miRNAs. Front. Cell Dev. Biol., 9.10.3389/fcell.2021.651161 ↗
14. Ji, X., Chen, X., and Yu, X. (2016). MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis. Int. J. Mol. Sci., 17.10.3390/ijms17030349 ↗
15. Mammoli, F., Castiglioni, S., Parenti, S., Cappadone, C., Farruggia, G., Iotti, S., Davalli, P., Maier, J.A.M., Grande, A., and Frassineti, C. (2019). Magnesium Is a Key Regulator of the Balance between Osteoclast and Osteoblast Differentiation in the Presence of Vitamin D3. Int. J. Mol. Sci., 20.10.3390/ijms20020385 ↗
16. Huber, J., Longaker, M.T., and Quarto, N. (2023). Circulating and Extracellular Vesicle-Derived microRNAs as Biomarkers in Bone-Related Diseases. Front. Endocrinol., 14.10.3389/fendo.2023.1168898 ↗
17. Della Bella, E., Menzel, U., Naros, A., Kubosch, E.J., Alini, M., and Stoddart, M.J. (2024). Identification of Circulating miRNAs as Fracture-Related Biomarkers. PLoS ONE, 19.10.1371/journal.pone.0303035 ↗
18. Circulating MiRNA-21-Enriched Extracellular Vesicles Promote Bone Remodeling in Traumatic Brain Injury Patients10.1038/s12276-023-00956-8 ↗
19. Bone Physiological Microenvironment and Healing Mechanism: Basis for Future Bone-Tissue Engineering Scaffolds
20. Immunomodulatory Biomaterials and Their Application in Therapies for Chronic Inflammation-Related Diseases10.1016/j.actbio.2021.01.025 ↗
21. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method10.1006/meth.2001.1262 ↗
22. Non-coding RNAs and Their Epigenetic Regulatory Mechanisms10.1042/BC20100029 ↗
23. An Update on Magnesium and Bone Health10.1007/s10534-021-00305-0 ↗
24. Barbagallo, M., Veronese, N., and Dominguez, L.J. (2021). Magnesium in Aging, Health and Diseases. Nutrients, 13.10.3390/nu13020463 ↗
25. Zhu, W., Wang, W., Yang, X., Ran, C., Zhang, T., Huang, S., Yang, J., Wang, F., Wang, H., and Wan, P. (2025). Research Progress on Osteoclast Regulation by Biodegradable Magnesium and Its Mechanism. Regen. Biomater., 12.10.1093/rb/rbaf026 ↗
26. Opportunities and Challenges for the Biodegradable Magnesium Alloys as Next-Generation Biomaterials10.1093/rb/rbw003 ↗
27. Costa, V., Raimondi, L., Scilabra, S.D., Pinto, M.L., Bellavia, D., De Luca, A., Guglielmi, P., Cusanno, A., Cattini, L., and Pulsatelli, L. (2025). Effect of Hydrothermal Coatings of Magnesium AZ31 Alloy on Osteogenic Differentiation of hMSCs: From Gene to Protein Analysis. Materials, 18.10.3390/ma18061254 ↗
28. Knecht, R.S., Bucher, C.H., Van Linthout, S., Tschöpe, C., Schmidt-Bleek, K., and Duda, G.N. (2021). Mechanobiological Principles Influence the Immune Response in Regeneration: Implications for Bone Healing. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.614508 ↗
29. Niu, Q., Gao, J., Wang, L., Liu, J., and Zhang, L. (2022). Regulation of Differentiation and Generation of Osteoclasts in Rheumatoid Arthritis. Front. Immunol., 13.10.3389/fimmu.2022.1034050 ↗
30. Ueta, M., Takaoka, K., Yamamura, M., Maeda, H., Tamaoka, J., Nakano, Y., Noguchi, K., and Kishimoto, H. (2019). Effects of TGF-β1 on the Migration and Morphology of RAW264.7 Cells in Vitro. Mol. Med. Rep.10.3892/mmr.2019.10662 ↗
31. Roles of Stromal Cell RANKL, OPG, and M-CSF Expression in Biphasic TGF-β Regulation of Osteoclast Differentiation10.1002/jcp.20036 ↗
32. Direct and Indirect Effects of Transforming Growth Factor-Beta on Osteoclast-Mediated Bone Remodeling Using a New in Vitro Bone Matrix Model10.1093/jbmrpl/ziaf104 ↗
33. Transforming Growth Factor-Beta Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells10.1074/jbc.273.42.27091 ↗
34. Collagen Type I Degradation Fragments Act through the Collagen Receptor LAIR-1 to Provide a Negative Feedback for Osteoclast Formation10.1016/j.bone.2018.09.006 ↗
35. IL13Rα2 as a Crucial Receptor for Chi3l1 in Osteoclast Differentiation and Bone Resorption through the MAPK/AKT Pathway10.1186/s12964-023-01423-7 ↗
36. Carvalheiro, T., Garcia, S., Pascoal Ramos, M.I., Giovannone, B., Radstake, T.R.D.J., Marut, W., and Meyaard, L. (2020). Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation. Front. Immunol., 11.10.3389/fimmu.2020.01793 ↗
37. Novel Insights into the Coupling of Osteoclasts and Resorption to Bone Formation10.1016/j.semcdb.2021.10.008 ↗
38. Salman, H.D., and Kadhim, M.M. (2021). MiRNA-133a and MiRNA-25 3p and Their Relationship with Some Variables in Serum of Patients with Osteoporosis. Arch. Venez. De Farmacol. Y Ter., 40.
39. miR-148a-3p Facilitates Osteogenic Differentiation of Fibroblasts in Ankylosing Spondylitis by Activating the Wnt Pathway and Targeting DKK110.3892/etm.2022.11292 ↗
40. MiR-351 Negatively Regulates Osteoblast Differentiation of MSCs Induced by (+)-Cholesten-3-One through Targeting VDR
41. MiR-206 Regulates the Progression of Osteoporosis via Targeting HDAC410.1186/s40001-021-00480-3 ↗
42. Chen, Y., Yang, Y.-R., Fan, X.-L., Lin, P., Yang, H., Chen, X.-Z., and Xu, X.-D. (2019). miR-206 Inhibits Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by Targetting Glutaminase. Biosci. Rep., 39.10.1042/BSR20181108 ↗
43. Synergistic Effects of miR-708-5p and miR-708-3p Accelerate the Progression of Osteoporosis10.1177/0300060520978015 ↗